Flunixin Meglumine Injectable solution (IM, IV)

Form: Injectable solution (IM, IV)

Strength: 100 mg/mL

Reference Brands: Banamine (US)

Category: Veterinary Product

Flunixin Meglumine injection is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in line with GMP and IVDR standards. In the US, FDA approval involves comprehensive clinical data and safety evaluations, mainly for pain and inflammation in horses, livestock, and pigs. In the EU, CE marking certifies conformity with veterinary medicinal regulations. These products undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective flunixin meglumine formulations worldwide.